Sunday, June 6, 2021

A Faltering Framework And Questionable Efficacy Of Covid Vaccines


Covid “Vaccines”: A Faltering Framework



On April 20, The Lancet published an analysis on the efficacy of the Covid injections. This analysis supports conclusions made in my earlier analysis. That being: the Covid injections are NOT “95% efficacious”.

Beyond the analysts’ tepid language couched in scientific jargon, the graphic that appears is quite startling.  As is often true, the devil lies in the details, in this case, the difference between relative risk reduction and absolute risk reduction. (For elaboration on these metrics, please see my article linked above).

From the “absolute risk reduction” you can calculate the “Number Needed to Vaccinate” which signifies approximately how many people must be injected to hypothetically benefit just one person. It is a metric every person needs to understand before taking the Covid injection.


Below are the Numbers Needed to Vaccinate (NNV) metrics for Covid “vaccines”:


For Pfizer, this number is estimated at 119. This means 119 people must be injected for it to reduce a “Covid” case in one person. Therefore, 118 of those people incurred (potential) risk with no benefit whatsoever.

Some estimates are even higher, according to The Lancet, data from the Pfizer rollout in Israel suggests an NNV of 217!

These NNV figures are likely underestimates, as there is significant obfuscation with trial data. The actual efficacy is likely even less than 1% as some of the injected groups who became ill with “Covid like symptoms” were fallaciously labelled as side effects, rather than potential breakthrough infections.

Also unaccounted for, in the lucky 0.84% of people who hypothetically benefitted from the “vaccine”, are the side effects. Efficacy metrics do not include adverse events from the injections. In other words, safety and efficacy are entirely different considerations. For example, even an efficacious intervention may not be safe if the risk of harm is high.




No comments:

Post a Comment